Background: Proton pump inhibitors (PPIs) have been associated with adverse events and increased mortality in patients diagnosed with cirrhosis (1). PPIs are commonly prescribed to patients with cirrhosis who present to the hospital with gastrointestinal bleeds (2). However, guidelines do not suggest routine usage of PPI in patients with cirrhosis without gastroesophageal reflux disease (GERD) [...]

Background: Proton Pump Inhibitors are widely misused in both the outpatient and inpatient setting. Often, they are initiated and continued for reasons that do not follow best practice guidelines. Purpose: A Proton Pump Inhibitor Stewardship Committee was created to address this problem as part of a Quality Improvement project. The goal was to determine the [...]

Case Presentation: Discussion45-year-old male with history of HIV on Antiretroviral and treated syphilis presented with painful oral lesions and difficulty swallowing which started several days after being placed on Nitazoxanide, Doxycycline, Levaquin, and Omeprazole for diagnosis of Helicobacter Pylori via Endoscopy done for diarrhea. He was given fluconazole for presumed thrush during ER visit. His [...]

Case Presentation: Gastroesophageal reflux disease (GERD) is a common disorder that is characterized by the backflow of gastric contents into the esophagus, leading to symptoms such as regurgitation and heartburn. While proton pump inhibitors (PPIs) are the mainstay of treatment, some patients experience refractory symptoms. Alternative therapeutic approaches of GERD may be warranted in these [...]